Totally agree with your comments & that of PortfolioPlus. Even...

First 7 Last

Share
Profile

Follow
freespins

892 Posts.

2

14/11/18

17:40

Post #: 36505669
Share

Originally posted by BertySmythe ↑

I also don't see the latest announcements as negative.

There has been no downgrade to expectations. There is no comapny guidance given for FY19 which understandably will worry some but at the same time I can understand that in the current market it would be quite difficult to forecast with the level of accuracy expected by the market..

The NTA at $3.92 per share does leave a a fair bit of room for upside capital management - and a process is underway so its not just talk.

FY18 underlying eps is 22 cents and FY19 should be close I imagine (perhaps a little less) and FY20 I would expect higher based on the development outlook. That's a P/E of 8-9.

Dividend at around 40-60%, last year 9 cents is quite ok at around a 5% yield.

In balance, the only downside I see is the value of property diminishing in the current environment but at the current share price that surely is well factored in.

So at today's share price it looks like a solid hold or buy - with one caveat. Fundamentals don't mean much if sentiment is against it, and the momentum is down so we still may see lower prices - and in my book, great value. .

Expand

Totally agree with your comments & that of PortfolioPlus. Even if the NTA was reduced to $3.40(just saying) then with SP at $1.70 (50%) its still leaves plenty of upside even for corporate play. Wanted to top up even though I have a swag of AOG, but was out most of the day. Its a definitely hold or buy at these levels. I'm not selling at these prices.

AOG Price at posting: $1.70 Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MTM

Australian Rare Earths bullish on early-stage uranium potential at Overland, SA

PME

Pro Medicus signs landmark $330M deal to roll out imaging platform in US hospitals

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

SHN

Chimeric clocks $4.17M R&D tax rebate from Canberra

Watchdog takes Webjet to court over alleged 'false' flight prices with hidden fees

OCN

Southern Cross Gold zooms in on 9 new high-grade zones above 20g/t at Golden Dyke

Chaos reigns markets – so let's take stock of where we're at ahead of December

There are more pages in this discussion • 6 more messages in this thread...

First 7 Last

Add AOG (ASX) to my watchlist

Totally agree with your comments & that of PortfolioPlus. Even...

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Australian Rare Earths bullish on early-stage uranium potential at Overland, SA

Pro Medicus signs landmark $330M deal to roll out imaging platform in US hospitals

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Chimeric clocks $4.17M R&D tax rebate from Canberra

Watchdog takes Webjet to court over alleged 'false' flight prices with hidden fees

Southern Cross Gold zooms in on 9 new high-grade zones above 20g/t at Golden Dyke

Chaos reigns markets – so let's take stock of where we're at ahead of December